MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Portfolio Companies: Osage
Aerie Pharmaceuticals, inc.-AERI
Organization & Developments: Aerie
Parents
Aerie Pharmaceuticals, inc.-AERI
Children
2015: Aerie Pharma Surges On Glaucoma Drug Trial Results AERI AGN MRK PFE
2016: Biotech Forum Daily Digest: Aerie Pharmaceuticals Soars On Trials, Novavax Implodes
2016: Biotech Forum Daily Digest: The Biotech Rally Continues. Amgen Gaining Strength. Spotlight On Aerie Pharmaceuticals
2017: Biotech Forum Daily Digest: Aerie Pharmaceuticals Garners Early FDA Approval
2019: Revisiting Aerie Pharmaceuticals_seekingalpha.com
Aerie has said AR-12286’s mechanism of action repairs the diseased tissue, restoring normal function to the eye.
Aerie’s glaucoma treatment candidate is AR-12286.
The compound is what’s called a Rho-kinase inhibitor.
Jumps
*Key People: Aerie
Finance & Acquisitions: Aerie